Free Trial

Cryoport (CYRX) News Today

$10.28
+0.02 (+0.19%)
(As of 05/31/2024 ET)
Trexquant Investment LP Buys 95,146 Shares of Cryoport, Inc. (NASDAQ:CYRX)
Trexquant Investment LP boosted its stake in shares of Cryoport, Inc. (NASDAQ:CYRX - Free Report) by 440.7% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 116,737 shares of the company's stock after
Cryoport, Inc. (NASDAQ:CYRX) Shares Sold by GW&K Investment Management LLC
GW&K Investment Management LLC reduced its holdings in shares of Cryoport, Inc. (NASDAQ:CYRX - Free Report) by 7.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 817,071 shares of the company's stock after sell
Cryoport, Inc. (NASDAQ:CYRX) Receives Average Recommendation of "Hold" from Analysts
Shares of Cryoport, Inc. (NASDAQ:CYRX - Get Free Report) have been given an average recommendation of "Hold" by the eight ratings firms that are presently covering the firm, MarketBeat reports. Six analysts have rated the stock with a hold recommendation and two have issued a buy recommendation on
Massachusetts Financial Services Co. MA Raises Holdings in Cryoport, Inc. (NASDAQ:CYRX)
Massachusetts Financial Services Co. MA increased its holdings in shares of Cryoport, Inc. (NASDAQ:CYRX - Free Report) by 46.9% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 1,992,895 shares of the company's stock after pur
Short Interest in Cryoport, Inc. (NASDAQ:CYRX) Declines By 5.6%
Cryoport, Inc. (NASDAQ:CYRX - Get Free Report) was the recipient of a significant decrease in short interest in the month of April. As of April 30th, there was short interest totalling 4,180,000 shares, a decrease of 5.6% from the April 15th total of 4,430,000 shares. Based on an average daily trading volume, of 470,800 shares, the days-to-cover ratio is currently 8.9 days. Currently, 8.7% of the company's shares are sold short.
Cryoport (NASDAQ:CYRX) Stock Price Down 4% Following Insider Selling
Cryoport (NASDAQ:CYRX) Stock Price Down 4% After Insider Selling
Richard J. Berman Sells 8,105 Shares of Cryoport, Inc. (NASDAQ:CYRX) Stock
Cryoport, Inc. (NASDAQ:CYRX - Get Free Report) Director Richard J. Berman sold 8,105 shares of Cryoport stock in a transaction dated Wednesday, May 15th. The shares were sold at an average price of $13.41, for a total transaction of $108,688.05. Following the completion of the transaction, the director now directly owns 100,000 shares of the company's stock, valued at $1,341,000. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website.
Leerink Partnrs Analysts Reduce Earnings Estimates for Cryoport, Inc. (NASDAQ:CYRX)
Cryoport, Inc. (NASDAQ:CYRX - Free Report) - Analysts at Leerink Partnrs cut their Q2 2024 EPS estimates for shares of Cryoport in a research report issued on Tuesday, May 7th. Leerink Partnrs analyst P. Souda now expects that the company will post earnings of ($0.37) per share for the quarter, d
Roth Capital Weighs in on Cryoport, Inc.'s Q2 2025 Earnings (NASDAQ:CYRX)
Cryoport, Inc. (NASDAQ:CYRX - Free Report) - Equities research analysts at Roth Capital issued their Q2 2025 earnings per share (EPS) estimates for shares of Cryoport in a research note issued to investors on Wednesday, May 8th. Roth Capital analyst R. Baldry anticipates that the company will pos
Cryoport (NASDAQ:CYRX) Shares Down 14.1% After Earnings Miss
Cryoport (NASDAQ:CYRX) Trading Down 14.1% After Earnings Miss
Cryoport's (CYRX) "Buy" Rating Reaffirmed at Needham & Company LLC
Needham & Company LLC restated a "buy" rating and set a $18.00 target price on shares of Cryoport in a research note on Wednesday.
Cryoport (NASDAQ:CYRX) Releases Earnings Results, Misses Estimates By $0.06 EPS
Cryoport (NASDAQ:CYRX - Get Free Report) released its quarterly earnings results on Tuesday. The company reported ($0.43) earnings per share for the quarter, missing analysts' consensus estimates of ($0.37) by ($0.06). The company had revenue of $54.59 million for the quarter, compared to analyst estimates of $58.78 million. Cryoport had a negative return on equity of 11.86% and a negative net margin of 42.69%. The firm's quarterly revenue was down 13.1% compared to the same quarter last year. During the same period in the previous year, the business posted ($0.16) EPS.
Cryoport (NASDAQ:CYRX) Lowered to Neutral at B. Riley
B. Riley downgraded shares of Cryoport from a "buy" rating to a "neutral" rating and cut their price target for the stock from $22.00 to $19.00 in a report on Friday.
Cryoport, Inc. (NASDAQ:CYRX) Short Interest Up 9.1% in April
Cryoport, Inc. (NASDAQ:CYRX - Get Free Report) saw a large growth in short interest during the month of April. As of April 15th, there was short interest totalling 4,430,000 shares, a growth of 9.1% from the March 31st total of 4,060,000 shares. Currently, 9.4% of the shares of the company are sold short. Based on an average daily volume of 445,600 shares, the short-interest ratio is presently 9.9 days.
New York State Common Retirement Fund Acquires 378,340 Shares of Cryoport, Inc. (NASDAQ:CYRX)
New York State Common Retirement Fund increased its holdings in Cryoport, Inc. (NASDAQ:CYRX - Free Report) by 29.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,642,752 shares of the company's stock after pu
Cryoport, Inc. (NASDAQ:CYRX) Given Consensus Rating of "Hold" by Analysts
Cryoport, Inc. (NASDAQ:CYRX - Get Free Report) has earned a consensus recommendation of "Hold" from the seven research firms that are currently covering the firm, Marketbeat.com reports. Five investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the com
CryoPort Inc
Cryoport, Inc. (NASDAQ:CYRX) Shares Bought by Vanguard Group Inc.
Vanguard Group Inc. lifted its position in shares of Cryoport, Inc. (NASDAQ:CYRX - Free Report) by 2.1% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 3,559,092 shares of the company's stock after buying an additional 74,0
Cryoport (NASDAQ:CYRX) Shares Gap Up to $18.34
Cryoport (NASDAQ:CYRX) Shares Gap Up to $18.34
Assessing CryoPort: Insights From 5 Financial Analysts
Cryoport (NASDAQ:CYRX) Receives Buy Rating from Jefferies Financial Group
Jefferies Financial Group restated a "buy" rating and issued a $21.00 target price (up from $17.00) on shares of Cryoport in a research note on Thursday.
Cryoport (NASDAQ:CYRX) Trading 5.1% Higher
Cryoport (NASDAQ:CYRX) Trading Up 5.1%
Short Interest in Cryoport, Inc. (NASDAQ:CYRX) Rises By 6.6%
Cryoport, Inc. (NASDAQ:CYRX - Get Free Report) was the recipient of a significant growth in short interest in March. As of March 15th, there was short interest totalling 4,170,000 shares, a growth of 6.6% from the February 29th total of 3,910,000 shares. Based on an average daily volume of 440,000 shares, the days-to-cover ratio is currently 9.5 days. Approximately 8.8% of the company's shares are sold short.
Cryoport, Inc. (NASDAQ:CYRX) Given Average Recommendation of "Hold" by Brokerages
Cryoport, Inc. (NASDAQ:CYRX - Get Free Report) has been given a consensus recommendation of "Hold" by the six brokerages that are presently covering the company, MarketBeat Ratings reports. Five analysts have rated the stock with a hold rating and one has issued a buy rating on the company. The
Assenagon Asset Management S.A. Has $21.58 Million Stock Holdings in Cryoport, Inc. (NASDAQ:CYRX)
Assenagon Asset Management S.A. boosted its position in shares of Cryoport, Inc. (NASDAQ:CYRX - Free Report) by 487.7% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 1,393,156 shares of the company's stock after buying an a
Insider Selling: Cryoport, Inc. (NASDAQ:CYRX) CFO Sells 1,079 Shares of Stock
Cryoport, Inc. (NASDAQ:CYRX - Get Free Report) CFO Robert Stefanovich sold 1,079 shares of the stock in a transaction that occurred on Monday, March 25th. The shares were sold at an average price of $17.54, for a total value of $18,925.66. Following the sale, the chief financial officer now directly owns 128,333 shares of the company's stock, valued at approximately $2,250,960.82. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.
Cryoport (NASDAQ:CYRX) Stock Price Down 4.5%
Cryoport (NASDAQ:CYRX) Shares Down 4.5%
Cryoport (NASDAQ:CYRX) Shares Down 4.5% Following Insider Selling
Cryoport (NASDAQ:CYRX) Stock Price Down 4.5% After Insider Selling
Insider Selling: Cryoport, Inc. (NASDAQ:CYRX) CFO Sells 1,035 Shares of Stock
Cryoport, Inc. (NASDAQ:CYRX - Get Free Report) CFO Robert Stefanovich sold 1,035 shares of Cryoport stock in a transaction on Friday, March 15th. The stock was sold at an average price of $15.43, for a total transaction of $15,970.05. Following the transaction, the chief financial officer now directly owns 123,662 shares of the company's stock, valued at $1,908,104.66. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.
Cryoport, Inc. (NASDAQ:CYRX) Sees Significant Decline in Short Interest
Cryoport, Inc. (NASDAQ:CYRX - Get Free Report) was the target of a significant decrease in short interest during the month of February. As of February 29th, there was short interest totalling 3,910,000 shares, a decrease of 7.1% from the February 14th total of 4,210,000 shares. Based on an average trading volume of 382,800 shares, the short-interest ratio is currently 10.2 days. Currently, 8.2% of the company's shares are sold short.
UBS Group Increases Cryoport (NASDAQ:CYRX) Price Target to $17.00
UBS Group boosted their price objective on shares of Cryoport from $14.50 to $17.00 and gave the company a "neutral" rating in a research report on Friday.
Analyst Ratings For CryoPort
Brokers Issue Forecasts for Cryoport, Inc.'s Q1 2024 Earnings (NASDAQ:CYRX)
Cryoport, Inc. (NASDAQ:CYRX - Free Report) - Equities research analysts at Leerink Partnrs cut their Q1 2024 earnings estimates for Cryoport in a research report issued to clients and investors on Tuesday, March 12th. Leerink Partnrs analyst P. Souda now anticipates that the company will earn ($0
Get Cryoport News Delivered to You Automatically

Sign up to receive the latest news and ratings for CYRX and its competitors with MarketBeat's FREE daily newsletter.

Claim Your Complimentary Bitcoin Reward (Ad)

Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.

Secure Your Spot Now

CYRX Media Mentions By Week

CYRX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CYRX
News Sentiment

0.74

0.64

Average
Transportation
News Sentiment

CYRX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CYRX Articles
This Week

2

3

CYRX Articles
Average Week

Get Cryoport News Delivered to You Automatically

Sign up to receive the latest news and ratings for CYRX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:CYRX) was last updated on 6/2/2024 by MarketBeat.com Staff

From Our Partners